[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Tasquinimod As a New Myeloma Therapy with Dan Vogl, MD and Yulia Nefedova, MD, PhD

Tasquinimod As a New Myeloma Therapy with Dan Vogl, MD and Yulia Nefedova, MD, PhD image

Tasquinimod As a New Myeloma Therapy with Dan Vogl, MD and Yulia Nefedova, MD, PhD

Podcast
event Jan 05, 2022 / 11:00AM MST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

When good immune cells like neutrophils and monocytes (which are usually immune system defenders) go rogue and become "pathologically activated", they can become something called myeloid-derived suppressor cells, or MDSCs. Instead of protecting us, these MDSCs help multiple myeloma grow. In this show, Dr. Vogl and Dr. Nefedova teach us what MDSCs are and how they work and how a new therapy called tasquinimod could help slow down myeloma growth. Learn more about this clinical trial using tasquinimod with ixazomib, lenalidomide and dex in combination to improve myeloma outcomes and slow myeloma growth. 

Thanks to our episode sponsor

Schedule & Agenda

Event panelist Dr. Dan Vogl, Dr. Yulia Nefedova, and Jenny Ahlstrom
11:00 AM
Discussion
Dr. Dan Vogl, Dr. Yulia Nefedova, and Jenny Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
Kite logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.